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ABSTRACT 
 
STUDIES ON THE INTERACTION AND ORGANIZATION OF BACTERIAL 
PROTEINS ON MEMBRANES 
 
MAY 2019 
 
MARIANA BRENA, B.A., WELLESLEY COLLEGE 
 
M.S., UNIVERSITY OF MASSACHUSETTS, AMHERST 
 
Directed by: Professor Alejandro P. Heuck 
 
 
Bacteria have developed various means of secreting proteins that can enter the 
host cell membrane. In this work I focus on two systems: cholesterol-dependent 
cytolysins and Type III Secretion.  
Cholesterol is a molecule that is critical for physiological processes and cell 
membrane function. Not only can improper regulation lead to disease, but also the role 
cholesterol plays in cell function indicates it is an important molecule to understand. In 
response to this need, probes have been developed that detect cholesterol molecules in 
membranes. However, it has been recently shown that there is a need for probes that only 
respond to cholesterol that is accessible at the membrane surface. Perfringolysin O (PFO) 
is a toxin secreted by Clostridium perfringens that has been developed into a probe 
capable of detecting accessible cholesterol. Recently, researchers have been expanding 
the capabilities of this probe by substituting residues, modifying residues, truncating the 
probe, or a combination of the three. However, lack of characterization of these new 
probes has led to controversial results. To understand the role of a conserved Cys residue, 
here we perform cholesterol binding assays and measure the pore formation activity of a 
Cys modified PFO derivative. 
 iv 
The Type III Secretion (T3S) system is a syringe-like apparatus used by various 
pathogens to inject effector proteins into target cells. The apparatus spans both the inner 
and outer bacterial membrane, extending to make contact with the host cell where it 
forms a pore known as the translocon. In Pseudomonas aeruginosa, the translocon is 
made up of two proteins, PopB and PopD. While recent advances have been made on the 
structure of the needle and injectisome, information on the translocon remains sparse. In 
this work, the P. aeruginosa T3S translocon is analyzed using both in vivo and in vitro 
methods. 
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 CHAPTER 1  
INTRODUCTION 
 
 
 
 
 
1.1 Bacterial pathogens secrete proteins that assemble complexes on the target cell 
membrane 
A common theme in bacterial pathogenesis is the need to communicate and interact 
with target cells. For this purpose, bacteria secrete proteins that bind, oligomerize, and 
form pores or channels in the plasma membrane of mammalian cells. For example, 
Gram-negative bacteria have dedicated secretion systems that span the bacterial 
membrane to secrete virulence factors (Costa et al 2015). Another common example of 
proteins secreted by bacteria that interact with host cell membranes include the family of 
pore forming toxins, which have a range of structures and pore forming mechanisms 
(Peraro and van der Goot 2016). In this work I will focus on two of these systems: the 
cholesterol-dependent cytolysins and the Type III Secretion system.  
1.2 Cholesterol-dependent cytolysins: sensing cholesterol at the target membrane 
1.2.1 Cholesterol 
Cholesterol is an important molecule responsible for the proper structure and 
function of membranes (Maxfield 2010). In the membrane, the non-polar tail of 
cholesterol is oriented to interact with the hydrophobic chains of other lipids, while the 
hydroxyl group interacts with the head groups of other lipids (Figure 1.1). It is a 
hydrophobic molecule that can cross membranes, but the concentration within 
membranes is tightly controlled because changes in concentration can result in changes in 
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mammalian membrane structure (Maxfield 2010).  Additionally, there are many proteins 
that sense, bind, and transport cholesterol, indicating the importance of cholesterol 
regulation (Maxfield 2010). Improper regulation of cholesterol can lead to diseases such 
as Niemman-Pick type C disease, Tangier disease, and atherosclerosis (Maxfield 2005). 
Due to the importance of proper cholesterol regulation, there is a need for probes to study 
cholesterol homeostasis and transport.  
1.2.2 Perfringolysin O 
Perfringolysin O (PFO) is a pore-forming toxin secreted by the Gram-positive 
pathogen Clostridium perfringens, and is part of a larger family of cholesterol-dependent, 
pore-forming toxins secreted by Gram-positive bacteria.  It is classified as a cholesterol-
dependent cytolysin (CDC) because it requires the presence of cholesterol in membranes 
in order to bind and form pores (Ohno-Iwashita 1992, Heuck et al 2000). When compared 
to PFO, many of the CDCs show an amino acid sequence identity greater than 39% 
(Heuck et al 2010).  
1.2.3 PFO binding mechanism 
Full-length PFO was arbitrarily divided into four different structural domains 
called domain 1 through 4 (Rossjohn 1997) (Fig 1.2). The PFO pore-formation 
mechanism can be described as follows: secreted as a 52.6 kDa water-soluble monomer, 
PFO first binds to cholesterol-containing membranes and oligomerizes with 35-40 other 
monomers to form a pre-pore complex. Lastly, PFO inserts β barrels to form a pore with 
a diameter of ~300Å in the target membrane (Fig. 1.3). The conformational changes 
required for PFO to insert into the membrane are initiated by the interaction between the 
distal loops found at the tip of the C-terminal domain, or domain 4 (D4), and the 
membrane (Ramachandran 2002). Upon D4 binding to the membrane, a conformational 
  3 
 
Figure 1.1 Cholesterol molecule and its orientation in the membrane. A. Depiction of the 
cholesterol molecule. B. The orientation in a membrane. Taken from Johnson 2014. 
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change causes domain 3 (D3) to expose a β strand required for monomer-
monomer contact, which then leads to oligomerization and alignment to form a pre-pore 
complex (Ramachandran 2004). This pre-pore complex then guides the insertion of two β 
hairpins per monomer into the target membrane (Shepard 1998, Shatursky 1999), which 
ultimately results in pore formation (Hotze 2002). Interaction with cholesterol is critical 
during membrane binding because it is sufficient to trigger the formation of PFO ring-
like complexes (Heuck 2007). Recently, it has become apparent that the interaction 
between PFO and cholesterol depends on how accessible cholesterol is at the membrane 
surface (Flanagan 2009, Johnson et al 2017).  
1.2.4 Cholesterol accessibility  
As previously mentioned, cholesterol is an important molecule for biological 
functions. Its interactions with other membrane components such as other lipids or 
molecules in the membrane dictate its ability to interact with molecules, such as PFO, at 
the surface of the membrane. For example, an increase in overall cholesterol 
concentration would result in more cholesterol exposed at the surface, or more accessible 
cholesterol (panel A, Fig. 1.3). Similarly, changes in the overall phospholipid 
composition will result in more or less cholesterol that is accessible at the membrane 
surface (panels B and C, Fig. 1.3).  
Probes such as extrinsic fluorophores that bind to cholesterol or intrinsically 
fluorescent sterols that mimic cholesterol have been successfully used as fluorescent 
reporters to study intracellular cholesterol transport (Maxfield 2012). However, it has 
been reported that some regulatory events in the cell are modulated by the changes in the 
accessibility of cholesterol at the membrane surface (and not total cholesterol content) 
  5 
 
 
Figure 1.2 The pore formation steps of PFO. The ribbon structure of Perfringolysin O is 
shown on the left with the four different domains highlighted in different colors: Domain 
1 is green, Domain 2 is yellow, Domain 3 is red, and Domain 4 is blue. The steps of the 
pore formation mechanism of PFO are illustrated as follows: PFO is secreted as a 
monomer before binding to a membrane (step I), where it then oligomerizes with other 
monomers (steps II and III) before inserting β hairpins to form a pore (step IV). Taken 
from Johnson 2014. 
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(Steck 2010). The aforementioned probes measure all cholesterol molecules and 
cannot detect changes in accessibility that could be triggered not only by changes in 
cholesterol concentration, but also by changes in the composition of other molecules in 
the membrane. 
Given that significant changes in cholesterol accessibility could be triggered by 
small changes on the total cholesterol content or no changes at all (i.e., changes on other 
lipids that affect cholesterol accessibility) it is difficult to measure cholesterol 
accessibility and its changes using probes designed to measure total cholesterol. To 
address this challenge, biosensors have been developed that bind to membranes only 
when cholesterol is accessible at the surface. Because PFO only recognizes accessible 
cholesterol, in contrast to other probes that report total cholesterol content in membranes, 
PFO as a probe is better suited to measure cholesterol accessibility. Because it is used as 
a cholesterol probe, it is necessary to understand the interaction between PFO and 
cholesterol.  
1.2.5 Domain 4 and cholesterol recognition 
 
The region in D4 responsible for cholesterol recognition consists of four loops 
interconnected by β strands located at the distal tip of the domain: L1, L2, L3, and the 
undecapeptide. Across all 28 members of the CDC family, these loops, specifically the 
undecapeptide, are highly conserved (Savinov and Heuck 2017) (Figure 1.4). There is a 
proposed cholesterol binding motif located in L1 composed of two residues, T490 and 
L491, that are conserved throughout every known CDC (Farrand et al 2010). However, 
the substitution of residues in any of loops at the tip of D4 causes the cholesterol-binding 
threshold of  
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Figure 1.3 Cholesterol accessibility depends on lipid composition. A) When overall 
cholesterol content increases. B) When the number of double bonds on acyl chains of 
phospholipid changes. C) When phospholipid head groups are modified. Taken from 
Johnson 2014. 
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PFO derivatives to shift, indicating the importance of this domain in the process 
of cholesterol recognition (Johnson 2012). This is echoed by the induced fit model of 
cholesterol interaction created by Savinov and Heuck that shows interaction between the 
loops in D4 and a cholesterol molecule (Savinov and Heuck 2017). However, the exact 
residues responsible for cholesterol recognition are not yet known.  
Despite the uncertainty, studies have been done on CDCs that demonstrate the 
importance of certain residues in pore formation. In CDCs such as Pneumolysin (PLY), 
substitution of the highly conserved Cys, which is located in the undecapeptide, with 
glycine or serine reduces the ability for the toxin to lyse polymorphonuclear leukocytes 
(Saunderst et al 1989). Additionally, substitution of other highly conserved residues near 
the Cys residue also causes reduced cell lysis (Korchev et al 1998). Early studies of other 
cytolysins such as Streptolysin O,  found that the addition of N-ethyl maleimde inhibited 
lysis of red blood cells (Oberley and Duncan 1971). In full-length PFO, it has been 
demonstrated that modification of the highly conserved Cys459 with a thiol-blocking 
agent decreases the hemolytic activity of the protein, therefore inactivating the toxin 
(Iwamoto 1987). Removal of the thiol-blocking agent with DTT caused the toxin to gain 
function again. In other words, modification of Cys459 alters the ability of full-length 
PFO to bind cholesterol.   
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Figure 1.4 The loops at the tip of D4 are highly conserved among CDCs A) Cartoon 
representation the PFO D4 β-sandwich showing the location of the loops and the 
conserved undecapeptide.The undecapeptide was colored red and the loops were colored 
green (L1), brown (L2), and blue undecapeptide was colored red and the loops were 
colored green (L1), brown (L2), and blue (L3); (B) (L3); (B) A view of the tip of PFO D4 
from the bottom showing the loops and undecapeptide color coded as in A; (C) Sequence 
alignment of the 28 CDC family members showing the conserved amino acids boxed and 
with dark grey background. Highly conserved amino acids are shown with a light grey 
background. Taken from Savinov and Heuck 2017. 
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1.2.6 PFO as a cholesterol probe 
As mentioned previously, PFO is unique in that its binding is modulated by 
cholesterol accessibility. Based on these properties, researchers have created a series of 
cholesterol probes based on CDCs.  By substituting amino acid residues in D4, it is 
possible to create probes with different cholesterol binding thresholds (Johnson 2012). 
Researchers have also been able to create a truncated probe that is non-lytic due to its 
inability to oligomerize by exploiting cholesterol-binding properties of the C-terminal 
domain, or D4 (Shimada 2002). The D4 of other CDC toxins has also been isolated and 
characterized, such as a CDC produced by Bacillus anthracis, anthrolysin O (ALO). Like 
PFO, ALO has also been shown to respond to cholesterol accessibility influenced by 
other lipids and not just total cholesterol concentration (Gay 2015). These D4 probes can 
also be further modified to alter the cholesterol threshold (Maekawa 2015) or by labeling 
cysteine residues with fluorophores (Gay 2015, Liu 2017).  Because of the use of PFO as 
a cholesterol probe, a precise knowledge of how PFO recognizes cholesterol is required 
to properly use it as a cholesterol sensor.  
Recently, lack of proper characterization has led to controversial results that are 
being debated in the literature. Liu et al reported that they were able to label the 
conserved Cys residue on isolated D4 with a fluorophore and lose sensitivity to lipid 
composition (Liu et al 2017). These surprising results spurred other researchers to study 
this labeled D4 probe more rigorously, where they were able to find that phospholipid 
composition does influence the binding of the D4 probe (Courtney et al 2018). Therefore, 
there is a need to characterize the effect of labeling the conserved Cys on D4.  
  11 
1.3 The Type III secretion system  
1.3.1 Type III Secretion 
Another mechanism of bacterial virulence is the Type III Secretion (T3S) system. 
The T3S system is a multi-protein complex found in many Gram-negative bacteria and 
used to inject effector proteins into host cells (Hueck 1998). Resembling a syringe, the 
different components of the T3SS include a cytosolic platform, a basal body that 
traverses the inner and outer bacterial membrane, the needle that extends from the 
bacterial membrane to the host cell membrane, and a translocon complex through which 
the effector proteins are translocated into the host cell (Deng et al 2017). The needle 
structure has been visualized in pathogens such as Y. enterocolitica (Kudryashev et al 
2013) S. flexneri, (Hu et al 2015) and S. typhimurium (Worrall et al 2016, Hu et al 2013, 
Park et al 2018).  
As shown in Figure 1.5, the T3S system spans the inner and outer bacterial 
membrane, with the needle portion extending to make contact with the host cell 
membrane, where the translocon is formed. While cryo-electron microscopy (cryo EM) 
has served as a helpful tool to analyze the different components and stoichiometry of the 
T3S system, or injectisome, there is limited information on the translocon (Worrall et al 
2016, Hu et al 2013). Further, there is limited structural information on the interaction 
between the needle tip and translocon, or the translocon and host membrane. Recently, 
more efforts have been made to understand the translocon. In contrast to the needle 
structures found by cryo EM, understanding of the translocon structure has been limited 
(Park et al 2018, Nauth et al 2018).  
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Figure 1.5 Schematic representation of P.aeruginosa needle and translocon.The structure 
of the T3S needle is shown in gray spanning the inner and outer membrane. The 
assembled translocon is depicted in blue and red, inserted on the host cell 
membrane.Effectors are shown in black with white chaperones. Image generated by Y. 
Tang 
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Figure 1.6 Hypothetical schematic of T3S system translocon formation and effector 
secretion. Upon activation, the needle secretes the translocators, PopB and PopD, either 
alternately or stochastically. They then assemble on the host cell membrane and secretion 
of effectors commences. Taken from Vermeulen et al 2016.  
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Upon contact with the host cell membrane, the T3S system is activated to secret 
effector proteins into the host cell (Pettersson et al 1996) (Fig. 1.6). Secretion can also be 
induced under low-calcium conditions (Goure 2004, Vallis 1999). Prior to injection of 
effector proteins into the host cell, the translocon must be assembled.  
1.3.2 Pseudomonas aeruginosa translocon 
In Pseudomonas aeruginosa, the translocon is formed by two proteins, PopB and 
PopD, 40 kDa and 31 kDa respecively. Upon T3S system activation, PopB and PopD are 
secreted and inserted into the host cell membrane through which Pseudomonas effectors 
ExoS, ExoT, ExoY, and ExoU are translocated into the host cell. Both PopB and PopD 
are required for effector translocation (Romano et al 2016). Without either translocator 
present, P. aeruguinosa is unable to successfully translocate proteins into host cells 
(Goure 2004). Unlike the injectisome, which has been visualized in other Gram-negative 
pathogens mentioned above, the translocon has yet to be visualized. The only structure 
available relating to the proteins that form the translocon is the crystal structure of PopB 
homologue, AopB, from Aeromonas hydrophila in complex with its chaperone, AcrH 
(Nguyen et al 2015).  
While the structure of the injectisome of the Type III Secretion system has been 
characterized in some Gram-negative pathogens, visualization of the translocon remains a 
challenge. Specifically, due to the non-polar nature of PopB and PopD, their interactions 
with the membrane, and the hetero-oligomeric organization, have been difficult to 
visualize. Nonetheless, important information on the assembly and orientation of the 
translocators has been discovered through biochemical analysis (Tang et al 2018). These 
studies are important because they help to model the arrangement of PopB and PopD in 
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the membrane and assist in our understanding on how they interact with each other and 
the needle. This knowledge could then be used to identify methods of disrupting the 
translocon and ultimately, P. aeruginosa infection.  
 In P. aeruginosa, the conditions to maximize translocon heterocomplex formation 
on model membranes have been previously established (Romano 2011), and by using 
single molecule analysis and fluorescence photobleaching, these membrane integral 
proteins have been found to assemble a heterocomplex with a distinct stoichiometry of 8 
subunits of PopB and 8 subunits of PopD (Romano 2016). More recent biochemical 
analysis of the translocon has shown that PopB assists the insertion of PopD into the host 
cell membrane (Tang et al 2018). Despite these advances, there is still a lack of 
information on the topology of the translocators in the membrane.  
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CHAPTER 2 
 CHARACTERIZATION OF THE PERFRINGOLYSIN O 
CHOLESTEROL-DEPENDENT BINDING WHEN THE 
CONSERVED CYS459 RESIDUE IS MODIFIED WITH 
COVALENTLY ATTACHED GROUPS 
 
 
 
2.1 Introduction  
Modifications to the loops at the tip of PFO D4 alter the affinity of PFO for 
cholesterol-containing membranes (Johnson 2012). Within one of these loops, the 
undecapeptide, there is a unique Cys459 that can be used to specifically introduce groups 
with different chemical characteristics. The introduction of these different groups can be 
used to study the forces that regulate PFO binding to membranes. While modifications to 
this Cys have been reported to be detrimental for protein hemolytic activity (Iwamoto et 
al 1987), recent results suggested that modifications to the Cys might alter the cholesterol 
dependent binding of PFO (Liu et al 2017). Here, we covalently attach fluorescent probes 
to the conserved Cys459 and measure the impact this modification has on the cholesterol 
binding and pore formation mechanism of PFO. 
2.2 Results 
In order further characterize which steps of the PFO mechanism, if any, are 
altered by modifying the conserved Cys, independent assays that measure binding, pore 
formation in vivo and in vitro were used. To see if modifying this residue causes full-
length PFO to lose sensitivity to lipid composition, as suggested by Liu et al, we 
modified the conserved Cys residue with two different fluorophores. We used two 
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probes, acrylodan or NBD, to modify Cys459 on wtPFO. Acrylodan is a hydrophobic 
fluorophore and was used by Liu et al in their studies. We also chose to label the 
conserved Cys with NBD because it is more polar than acrylodan, and it has a lower 
tendency to locate into the membrane. The effect of the fluorophore on PFO derivatives 
was then characterized by independently measuring their cholesterol binding threshold, 
the effect of lipid composition, their hemolytic activity, and their pore formation activity 
in model membranes, and the results were compared to wtPFO.  
2.2.1 Cholesterol binding 
PFO contains 6 of the 7 native tryptophan (Trp) residues in D4, which allows us to 
directly monitor binding using intrinsic Trp emission. When PFO binds to membranes, 
these Trp residues locate into a non-polar environment, which causes them to display an 
increase in fluorescence when compared to the polar environment sensed by these 
residues when PFO is monomeric in an aqueous solution. A sharp increase in the intrinsic 
fluorescence of PFO is observed in a relatively narrow range of cholesterol concentration 
(~4 mol%) when PFO is incubated with liposomes containing increasing amounts of 
cholesterol. The cholesterol concentration that produces 50% binding of PFO is defined 
as the cholesterol binding threshold. For wtPFO, the cholesterol threshold was 
determined by Johnson et al by quantifying cholesterol concentration and phospholipid 
concentration in liposomes containing 1:1:1 molar ratio of POPC, POPE, and SM (Figure 
2.1) (Johnson et al 2012). Based on this quantification, wtPFO can be used as a reliable 
reference. Liposomes containing 30-50 mol% cholesterol and a 1:1:1 molar ratio of 
POPE:POPC:SM were prepared and the cholesterol binding threshold was determined by 
incubating liposomes with labeled and unlabeled PFO and measuring the resulting 
increase in the dye fluorescence or intrinsic fluorescence as a function of cholesterol 
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concentrations, respectively. The introduction of a modification on Cys459 did not seem 
to significantly alter the cholesterol binding threshold, although the fluorophore-labeled 
PFO derivatives did not have as sharp a response as wtPFO (Figure 2.2).  
 
 
Figure 2.1 Determination of the cholesterol threshold for nPFO (final concentration of 
200 nM) on POPC/POPE/SM membranes containing the indicated mole percent of 
cholesterol (final total lipid concentration of 100 μM). The mole percent of cholesterol 
was determined by individual quantification of cholesterol and total phospholipids. 
Cholesterol was quantified using Amplex Red, and total phospholipids were quantified 
by phosphate determination after acid hydrolysis as described in Experimental 
Procedures. Thin lines are a guide for the eye to indicate the average range for data in the 
transition. Taken from Johnson et al 2012.  
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Figure 2.2. Modification of Cys459 does not significantly alter chol binding in liposomes. 
Proteins were incubated with two different set of liposomes (open and closed symbols) 
containing a 1:1:1 ratio of POPC:POPE:SM and the indicated cholesterol concentration 
for 20 min at 37 ˚C. The final fluorescence, F, was divided by the initial fluorescence, F0. 
Final protein concentration was either 200 nM for NBD-labeled PFO and wtPFO or 160 
nM for acrylodan-labeled PFO. The final lipid concentration was 200 µM. Acrylodan 
labeling was 100% (Batch 1) and NBD labeling was 81% (Batch 1).  
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2.2.2 Lipid sensitivity 
In order to observe how the lipid composition affects the cholesterol-dependent 
binding of Cys-labeled PFO, liposomes containing 20-50 mol% cholesterol and DOPC 
were prepared and incubated with wtPFO and labeled PFO. Compared to the lipid 
composition used in Fig. 2.2, this lipid composition will contain more unsaturated acyl 
chains. More unsaturated acyl chains will decrease the amount of cholesterol required to 
trigger PFO binding (Flanagan et al 2009). This should lead to a lower cholesterol 
binding threshold when compared to the one obtained using liposomes with a 1:1:1 
SM:POPE:POPC lipid composition. As expected, there was a lower cholesterol binding 
threshold for wtPFO (solid blue circles compared to open blue circles, Figure 2.3). 
Additionally, the labeled PFO derivatives exhibited a shift in cholesterol binding 
threshold (green and red symbols, Figure 2.3).  However, while the profile for NBD-
labeled PFO was similar to the binding curve for wtPFO (right panel, Figure 2.3), the 
profile for acrylodan-labeled PFO was different from wtPFO (left panel, Figure 2.3). The 
threshold for acrylodan-labeled PFO decreased from approximately 35 mol% cholesterol 
to 15 mol% cholesterol (left panel, Fig. 2.3).  
2.2.3 Pore formation 
While measuring intrinsic Trp emission is indicative of PFO binding, measuring 
pore formation is indicative of the ability for PFO to oligomerize and insert the 
transmembrane β barrels. In order to measure pore formation, liposomes containing the 
fluorescent complex Tb(DPA)33- were prepared with a high cholesterol concentration (50 
mol%). The binding reaction was carried out in buffer containing the membrane-
impermeable EDTA, which chelates Tb3+ and quenches its emission. When pores are  
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Figure 2.3 Labeled and unlabeled PFO is sensitive to lipid composition. Liposomes (200 
µM final concentration) containing DOPC and the indicated cholesterol concentration 
were incubated with either 200 nM wtPFO or NBD-labeled PFO or 160 nM acrylodan-
labeled PFO for 20 min at 37 ˚C. The emission after liposomes incubation (F) was 
divided by emission for monomeric PFO before addition of the liposomes (F0). NBD 
labeling was 92% (Batch 2) and acrylodan labeling was 100% (Batch 4). 
 
 
 
 
 
 
 
 
 
 
  22 
formed in the liposomes, EDTA is able to access the encapsulated Tb(DPA)33-   
complexes. Therefore, a decrease in fluorescence correlates to pore formation. As seen in 
Figure 2.2, a cholesterol concentration of 50 mol% results in both wtPFO and labeled 
PFO being maximally bound to the membranes. Therefore, we used this cholesterol 
concentration to ensure maximum PFO binding. As with wtPFO, both labeled PFO 
derivatives tested were able to form pores in liposomes. However, in contrast to similar 
thresholds in the cholesterol binding assays, the labeled PFO derivatives showed slightly 
lower pore formation activity when compared to wtPFO (Figure 2.4). The protein 
concentration-dependent quenching of wtPFO parallels the one observed for NBD-
labeled PFO. Acrylodan-labeled PFO showed lower pore formation activity and 
plateaued above 100 nM protein (Figure 2.4).  While more experiments will be required 
to explain the small differences observed for the acrylodan-labeled PFO and the wtPFO, 
it is clear that the three proteins were able to perforate the liposomal membrane and form 
pores. 
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Figure 2.4 NBD and acrylodan-labeled PFO can form pores in cholesterol-containing 
liposomes. Liposomes with a high percentage of cholesterol (50 mol%) were prepared 
containing Tb(DPA)33-   ions. Fluorescence was measured before and after incubation 
with the indicated protein. The average of two experiments are shown with error bars 
indicating range. Acrylodan-labeled PFO was 100% labeled (Batch 3) and NBD-labeled 
was 92% labeled (Batch 2).  
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2.2.4 Hemolysis 
While cholesterol binding and pore formation are measured using model 
membranes, or liposomes, red blood cells (RBCs) can also be used to measure PFO-
membrane interactions with more complex natural membranes. In order to accomplish 
this, RBCs were incubated with wtPFO or labeled-PFO for 20 minutes at 37 ˚C. The 
resulting lysis of the RBCs was measured by pelleting RBCs and measuring the 
hemoglobin released into the supernatant.  
Both fluorophore-modified PFO derivatives were able to lyse RBCs at 
concentrations above 10 nM, however, NBD-labeled PFO required a ten-fold increase of 
protein to reach 50% hemolysis when compared to wtPFO (Figure 2.5). Acrylodan-
labeled PFO showed an intermediate concentration-dependent response. These results 
confirmed that despite the small differences observed for the lytic activity of the Cys459-
labeled PFO derivatives, all of them were able to form pores in model and natural 
membranes.  
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Figure 2.5. NBD-labeled PFO requires 10-fold higher concentration of protein to lyse red 
blood cells. Washed red blood cells were incubated with the indicated concentration of 
protein for 20 min at 37 ˚C. Hemoglobin release was recorded by pelleting cells and 
measuring absorbance at 540 nm using a plate reader. The average of two experiments is 
shown with error bars indicating range. Acrylodan labeling was 100% (Batch 3) and 
NBD labeling was 81% efficient (Batch 1). 
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2.3 Discussion 
Wild-type PFO contains a unique Cys located in one of the loops at the tip of the 
D4 β -sandwich. This Cys was labeled with either the fluorophores IANBD (NBD) or 
acrylodan, and the properties of labeled PFO derivatives were compared to wtPFO 
(unlabeled protein) by measuring ability to bind to cholesterol-containing membranes and 
form pores. The cholesterol binding threshold was not significantly affected by covalent 
modification with these fluorescent dyes. Additionally, we measured pore formation 
ability to determine if the modified PFO can oligomerize and insert the β-barrel pore and 
found that the labeled PFO derivatives had slightly lowered pore formation activity, but 
were still able to form pores in cholesterol containing liposomes. Lastly, we measured the 
hemolytic activity of wtPFO and its labeled derivatives to demonstrate if the Cys-labeling 
affects lysis of natural cholesterol-containing membranes, finding that both derivatives 
were able to lyse red blood cells albeit requiring 10-fold more protein in the case of 
NBD-labeled PFO and a slightly higher concentration of acrylodan-labeled PFO.  
 Because of the results reported in Liu et al (2017), we chose to use acrylodan as 
one of our fluorophores. In addition to acrylodan, we used NBD, which is less 
hydrophobic than acrylodan, to observe the effect of hydrophobicity on the Cys residue. 
Our results show that modification with NBD and acrylodan to the conserved Cys residue 
in PFO does not significantly alter the cholesterol binding threshold (Figure 2.2) nor does 
it cause PFO to lose lipid sensitivity (Figure 2.3). However, it appears that pore formation 
in liposomes and red blood cells for labeled-PFO derivatives is not as efficient as wtPFO. 
Previous studies have found that substituting the native Cys residue for an alanine 
residue causes an increased shift in the cholesterol binding threshold of 4 mol% 
cholesterol (Moe and Heuck 2010). Therefore, we expected to see an increase in the 
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cholesterol binding threshold when comparing Cys-modified PFO to wtPFO. It was 
surprising to see that there was not a significant difference in the cholesterol binding 
threshold between labeled and unlabeled PFO. However, it did appear that labeling PFO 
with a fluorophore caused the loss of the sharp response to an increase in the mol% 
cholesterol typically seen in wtPFO. In wtPFO, the binding threshold typically begins at 
around 36 mol% cholesterol and ends at approximately 40 mol% in liposomes containing 
the indicated cholesterol concentration and a 1:1:1 ratio of SM:POPE:POPC (Figure 2.1, 
Johnson et al 2012, 2017). This sigmoidal curve was replicated here, (blue circles in 
Figure 2.2), but a similarly sharp curve was not seen for acrylodan-labeled PFO or NBD-
labeled (Figure 2.2). There was still a response to the increase in cholesterol, but the 
threshold was not as narrow as it is for wtPFO. This is likely due to the modification of 
Cys459. D4 is the first domain of PFO that comes into contact with membranes and if the 
conserved Cys or other residues in D4 are modified, there is a clear shift in the 
cholesterol binding threshold to higher cholesterol concentrations (Johnson et al 2012). 
Therefore, the addition of a fluorophore to D4 may explain the “extension” of the 
sigmoidal curve. Additionally, when measuring the cholesterol binding thresholds for 
PFO and the labeled derivatives, we are measuring fluorescence as the environment of 
either Trp or the fluorophore changes. It is possible that acrylodan and NBD emission is 
more affected by cholesterol concentration than Trp residues are. This could explain why 
there are variations in F/F0 at high cholesterol concentrations even though maximum 
binding has been reached for wtPFO and may explain why the cholesterol binding curve 
for the labeled PFO derivatives is flatter than the curve for wtPFO. 
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In contrast to the acrylodan-labeled D4 probe used by Liu et al, we did not find 
that labeling full-length PFO with NBD or acrylodan causes a loss of lipid sensitivity 
(Figure 2.3). To test this, the cholesterol binding curve for PFO and liposomes containing 
cholesterol and DOPC was measured using increase in Trp or fluorophore fluorescence as 
a guide for membrane binding. As expected for the DOPC liposome binding curve, the 
1:1:1 SM:POPC:POPE liposome curve, shifted towards lower cholesterol concentration 
for wtPFO, NBD-labeled PFO, and acrylodan-labeled PFO. These results are in 
agreement with previous findings on the sensitivity of PFO to lipid composition 
(Flanagan 2009, Johnson et al 2017). 
In the two assays that measure the ability for PFO to form pores, pore formation 
in liposomes and hemolytic activity, the labeled PFO derivatives were less able to form 
pores than wtPFO (Figure 2.4 and 2.5). This may be because while the modification on 
D4 does not impede cholesterol recognition, however it may affect the downstream 
conformational changes required for oligomerization and insertion of the β hairpins. 
During the binding mechanism, dimer formation causes conformational changes which 
then leads to oligomerization (Ramachandran 2004). The addition of a bulky molecule on 
Cys459 may impact dimerization or oligomerization, which would also explain the 
lowered hemolytic activity and pore formation activity in the labeled PFO derivatives.  
Acrylodan-labeled PFO was able to lyse RBCs more efficiently than NBD-labeled 
PFO. This was in contrast to the pore formation results, which showed that NBD-labeled 
PFO formed more pores than acrylodan-labeled. This may be explained by the use of 
different samples for the two experiments. Both of these assays used the same batch of 
acrylodan-labeled PFO (Batch 3) but a different batch of NBD-labeled PFO with 
  29 
different labeling efficiencies. In the pore formation assay, PFO was labeled with NBD 
with an efficiency of 92%, while in the hemolytic activity assay, the labeling efficiency 
was 81%. The presence of two different populations, labeled and unlabeled protein, mean 
that in addition to observing the interaction between the protein and the membranes, we 
observe the interaction between labeled and unlabeled protein. It was previously shown 
that mixing functional PFO with a PFO derivative that is unable to insert the β hairpins 
due to a Y181A substitution will induce the insertion of the β hairpins on the Y181A 
derivatives (Hotze et al 2002). Given our results, we may be observing two different 
populations at play: an unlabeled and a labeled population. Additionally, while the 
binding assay was normalized by the initial concentration of protein (F0), the differences 
observed in these pore formation assays could originate in small differences in the 
calculated concentration of the proteins (despite the efforts to correct for the fluorescence 
contribution of acrylodan and NBD to the absorbance at 280 nm). 
It has been established that during pore formation, D4 and D3 are 
conformationally linked (Heuck et al 2000). Additionally, D4 binding to the membrane is 
the switch that causes the conformational changes necessary for pore formation (Heuck et 
al 2007). It is therefore possible that modifications to the Cys459 in D4 can contribute to 
a decreased ability to form pores in membranes. While there was no significant difference 
in terms of cholesterol binding threshold, we did see that labeling PFO on the conserved 
Cys does not impair its ability to react to changes in cholesterol accessibility.  
 Given these results, it would be surprising that labeling Cys459 would cause a 
truncated D4 probe to lose lipid sensitivity. However, more studies are necessary to 
understand the mechanism behind cholesterol recognition and pore formation in PFO.   
  30 
2.4 Materials and methods 
2.4.1 Protein overexpression and purification 
As reported previously in Flanagan et al 2009. The concentration of protein was 
estimated by measuring absorbance at 280nm and using a molar absorption coefficient of 
74,260 M-1cm-1. Protein was stored with 10% glycerol and 5mM DTT at -80˚C after 
being flash frozen with liquid nitrogen.  
2.4.2 Fluorophore preparation 
Using a glass pipet, a small amount of fluorophore (N,N'-Dimethyl-N-
(Iodoacetyl)-N'-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Ethylenediamine (IANBD amide, 
Invitrogen) or 6-Acryloyl-2-Dimethylaminonaphthalene, (acrylodan, Thermo Fisher) was 
added to 100µL DMSO. The fluorophore was dissolved thoroughly before being 
centrifuged for 5 min at 16000 x g to remove any insoluble material. The supernatant was 
transferred to a new tube and a 1:500 dilution was prepared using spectroscopic grade 
methanol. To determine the concentration of the sample, the concentration of the 
fluorophore was determined by measuring the absorbance at 502nm for NBD or 372nm 
for acrylodan and using the molar absorptivities of 25,000 M-1cm-1 for NBD or 16,400 M-
1cm-1 for acrylodan in methanol (Molecular probes catalogue).  
2.4.3 Fluorophore labeling of native Cys residue 
 Purified wtPFO was loaded onto a column packed with Sephadex G-25 resin (GE 
Healthcare) and pre-equilibrated with 50 mM Hepes pH 8.3, 100 mM NaCl (HBS pH 
8.3) to remove DTT. Protein was collected in 20-drop fractions and concentration was 
measured using absorbance at 280 nm. A final concentration of 3 M guanidine 
hydrochloride crystals were added to pooled peak fractions of protein. This sample was 
then incubated in a 1:10 molar excess of fluorophore for two hours with gentle rocking. 
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To remove excess fluorophore and guanidine hydrochloride, labeled protein was loaded 
on to a second Sephadex G-25 column equilibrated with 50 mM Hepes pH 7.5, 100 mM 
NaCl. Peak fractions were collected and the concentration of the fluorophore and protein 
was determined. Labeling efficiency was calculated by dividing the concentration of the 
fluorophore by the concentration of PFO by using the molar absorptivities of 25,000 M-
1cm-1 for NBD, 16,400 M-1cm-1 for acrylodan, and 74,260 M-1cm-1 for PFO. To account 
for fluorophore contribution to absorbance of the protein, the absorbance of the 
fluorophore alone was measured at both the wavelength used to measure the fluorophore 
and at 280 nm. The absorbance contribution of the fluorophore to the absorbance of 
protein at 280 nm was calculated as follows: for NBD, Abs 280/ Abs 502 = 0.05 and for 
acrylodan, Abs 280/ Abs 372 = 0.2. Therefore, to determine the concentration of PFO for 
NBD-labeled PFO, 5% of the absorbance at 502 nm was subtracted from the protein 
absorbance while 20% of the absorbance at 372 nm was subtracted from the protein 
absorbance for acrylodan-labeled PFO. The chemical reaction that takes place between 
the fluorophore and the cysteine is shown in Figure 2.6. 
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Figure 2.6 Fluorophore conjugation with sulfhydryl group on cysteine. (A) The reaction 
between IANBD and the conserved cysteine takes place between the iodoacetamide 
group on NBD and the sulfhydryl group on the cysteine. (B) The reaction between 
acrylodan (represented by the acryloyl derivative) and the sulfhydryl group.  
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2.4.4 Preparation of liposomes 
 All lipids except cholesterol (Steraloids) were from Avanti Polar Lipids. Lipids 
are stored dissolved in chloroform. The desired lipid composition was mixed well in a 
glass tube before the chloroform was evaporated using a gentle stream of nitrogen gas to 
form a lipid film on the bottom of the glass tube. The lipid films were further dried in a 
SpeedVac for 3 hours and then stored at -20˚C until the lipid film was resuspended in 
buffer containing 50mM Hepes pH 7.5 and 100mM NaCl (HBS pH 7.5) at 20-23 ˚C for 
45 minutes. The resuspended lipids were then subjected to three freezing (-80˚C) and 
thawing (37˚C) cycles, each freeze or thaw step lasting 5 minutes. After the final thawing 
step, the lipids were passed through an extruder with a 0.1 µm membrane 21 times to 
form large unilamellar vesicles (liposomes). The liposomes were stored on ice at 4˚C for 
up to two weeks. 
2.4.5 Preparation of liposomes containing Tb(DPA)33- 
 Lipids dissolved in chloroform were mixed containing a 1:1:1 mol% ratio of 
sphingomyelin (SM), 1-palmitoyl-2-oleoyl-glycero-3-phosphocholine (POPC), and 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 50% cholesterol 
(Steraloids, RI). The lipid films were dried as described above but were resuspended in 
buffer containing HBS pH 7.5, 9 mM DPA pH 11.5, and 3 mM TbCl3 pH 5 for at least 
half an hour. After rehydration for 30 min, the lipids were subjected to the freeze and 
thaw cycle and extruded as described above. Next, the vesicles were run through a 
column packed with Sephadex G-25 Medium resin (GE Healthcare) and equilibrated with 
HBS pH 7.5 to remove Tb(DPA)33-  ions not encapsulated by lipids. Fractions were 
collected in 20-drop aliquots. The concentration of lipids was estimated by measuring 
scatter at three different wavelengths and using the curves in Figure 2.7.  
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Figure 2.7 Absorbance of liposomes at different wavelengths as a function of lipid 
concentration.  
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2.4.6 Analysis of cholesterol binding threshold 
 In order to establish the cholesterol binding threshold of the labeled PFO, 
liposomes were prepared using a range of 30-50 mol% cholesterol with a 1:1:1 mol% 
ratio of SM, POPC, and POPE. Protein at a final concentration of 200 nM was added to 
buffer containing 50 mM Hepes pH 7.5, 100 mM NaCl, 1mM DTT, and 0.5 mM EDTA, 
and liposomes of indicated cholesterol concentrations with a final total lipid 
concentration of 200 µM. Samples were incubated for 20 min at 37 °C in a final volume 
of 300 µL. PFO binding was determined using the intrinsic Trp emission at 20 oC before 
(F0) and after addition of liposomes (F). Values at each cholesterol mol % are the average 
of two measurements and the errors bars indicate the range. In the case of the labeled 
proteins, the increase in fluorescence of the fluorophore was measured. The excitation 
and emission wavelengths and slits for wtPFO and the labeled derivatives used are 
described in Table 2.1. 
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Table 2.1 Excitation and emission wavelengths and respective slit widths for measuring 
wtPFO and the labeled derivatives.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Excitation wavelength, 
Slit width 
Emission wavelength, 
Slit width 
wtPFO 295 nm, 2 nm 348 nm, 4 nm 
NBD 470 nm, 2 nm 530 nm, 4 nm 
Acrylodan 380 nm, 2 nm 445 nm, 2 nm 
  37 
 
To examine the lipid composition sensitivity of labeled PFO, liposomes 
containing 0-50 mol% cholesterol and 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) were prepared and the aforementioned assay was repeated. The resulting 
cholesterol binding threshold was compared to the binding threshold for the 1:1:1 mol% 
ratio SM:POPC:POPE-containing liposomes. 
2.4.7 Analysis of pore formation 
To examine the ability of the labeled derivatives to form pores in cholesterol-
containing membranes, the quenching of terbium (Tb3+) in terbium-containing liposomes 
by EDTA will be examined. Liposomes containing Tb(DPA)33- were prepared with a 
1:1:1 mol% ratio of SM, POPC, and POPE and 50 mol% cholesterol as described above. 
Their initial fluorescence was measured in a buffer containing EDTA, which cannot 
quench fluorescence of Tb3+ ions encapsulated in the liposomes. Addition of PFO and 
subsequent pore formation allows EDTA in the buffer to enter the liposomes, quenching 
Tb3+ fluorescence. Therefore, a resultant decrease in fluorescence indicates that PFO was 
able to make pores in the liposomes. Fluorescence was measured using an excitation and 
emission wavelengths of 278 nm and 544 nm, and slit widths of 2 nm and 4 nm 
respectively. A filter was placed in the emission slit to block emission wavelengths under 
300 nm (Barela and Sherry 1976).  
2.4.8 Lysis of natural cholesterol-containing membranes by PFO 
 To measure the hemolytic activity of PFO and the labeled derivatives, protein was 
serially diluted to the indicated concentrations in a 96-well plate prior to addition of equal 
volumes of 1% washed sheep red blood cells (RBCs) for a final volume of 250 µL. RBCs 
were incubated with PFO for 20 minutes at 37 ˚C. The intact RBCs were pelleted by 
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centrifugation at 3500 x g for 10 min at 4 ˚C. 200 µL of the supernatant was then moved 
to a new plate where hemoglobin release was measured using absorbance at 540 nm on a 
plate reader. These values were corrected to 100% hemoglobin release caused by 
incubation of RBCs with water (causing osmotic shock) and spontaneous hemoglobin 
release when RBCs were incubated without PFO.  
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 CHAPTER 3  
 ANALYSIS OF THE TYPE III SECRETION 
TRANSLOCON  
 
 
 
3.1 The role of PopB in PopB/PopD heterocomplex formation 
It has been established that P. aeruginosa translocons formed when PopB and 
PopD are added to liposomes consist of 8 PopD monomers and 8 PopB monomers 
(Romano 2016). When individually added, PopB and PopD form mostly hexamers 
(Romano 2016). If either translocator is absent, P. aeruginosa is unable to translocate 
toxins into the host cell (Goure 2004), suggesting that only hetero-oligomers are 
functional for protein translocation. One possible hypothesis for the shift in the 
stoichiometry of the oligomers is that the translocators form heterodimers and these 
heterodimers only interact with other heterodimers. In order to investigate the interaction 
between PopD monomers and PopB/PopD, glutaraldehyde was used as a crosslinker to 
capture complexes assembled on membranes when PopD was added alone or with an 
excess of PopB. The interaction was tested by crosslinking and covalently attached 
subunits were separated in the presence of a strong detergent, Triton X-100. 
3.1.1 Addition of PopB assists PopB/PopD heterocomplex formation 
 
In order to efficiently form PopB/PopD complexes on membranes, purified PopD 
and PopB were added to liposomes at acidic pH (pH 4.3) as described previously 
(Romano 2016). Previous data has shown that an excess of PopB is needed to force PopD 
into heterocomplexes and minimize formation of homo-complexes. The reconstitution 
reaction contained a 7:1 molar ratio of PopB to PopD with a total protein to lipid ratio of 
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1:6000 (Romano et al 2016). After inserting into the membrane, assembled complexes 
were crosslinked with glutaraldehyde and analyzed via western blot.  
When PopD alone was incubated with liposomes, high-order oligomers that 
correspond to PopD dimers (62.6 kDa), trimers (93.9 kDa), and pentamers (156.5 kDa) 
were observed (Figure 3.1). However, with the addition of PopB, there is a clear shift in 
bands, which correlate to PopB and PopD complexes (right lane, Figure 3.1). This 
indicates that the addition of PopB redirects the oligomerization state of PopD from 
homo-oligomers to hetero-oligomers.  
Previous results suggested that PopD homo-oligomers were stable to Triton X-
100, but not the hetero-oligomers (for example, the inability to purify heterocomplexes, 
unpublished results). In order to understand the stability of this interaction, PopD alone 
and PopB and PopD were allowed to form oligomers and then incubated with Triton X-
100 to solubilize the membrane. Association of the complexes was tested using 
glutaraldehyde crosslinking. The complexes that remained associated were then captured 
by crosslinking, while dissociated complexes were not. Crosslinking experiments 
corroborated that PopD alone is stable to solubilization with Triton X-100 but PopB and 
PopD are not able to form stable complexes in the presence of Triton X-100 (Figure 3.2). 
The addition of Triton X-100 is able to disassociate PopB/PopD complexes as shown by 
the lack of bands at molecular weights above the PopD monomer (31 kDa).  
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Figure 3.1 Capturing complexes with glutaraldehyde glutaraldehyde cross-linking of 
PopD homo-oligomers and PopB and PopD hetero-oligomers formed on liposomes. 
PopD alone or premixed with an excess of PopB were incubated with liposomes in buffer 
B for 20 min with a protein:lipid ratio of 1:5000. Proteoliposomes were pelleted and 
subjected to immunoblotting using an anti-PopD antibody. Expected molecular masses 
for PopD n-mers (left) and PopD:PopB n-mers (right) were estimated using the molecular 
mass for PopD (31.3 kDa) and PopB (40.1 kDa) monomers. Published in Tang et al 2018. 
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Figure 3.2 PopD homo oligomers are stable to Triton X-100 solubilization while 
PopB/PopD heterocomplexes are not. PopB/PopD or PopD alone was added to liposomes 
at pH 4.3 before the addition of Triton X-100. The resulting complexes were crosslinked 
with glutaraldehyde to capture oligomers stable to Triton X-100 before TCA precipitating 
and western blotting against PopD. 
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3.2  ybbR tag inserted into PopD after residues 40 and 208 does not impede the 
formation of a functional translocon 
It has been established that the conformation of PopD is influenced by the 
presence of the other translocator, PopB (Tang et al 2018). Additionally, it is known that 
in vivo, the N terminal region of PopD is exposed to host cell cytosol (Tang et al 2018). 
By using strategically placed GSK tags that are phosphorylated only when exposed to the 
host cell, Tang was able to explore the topological arrangement of PopD in functional 
translocons (Tang 2018). Phosphorylation experiment results showed that PopD 
derivatives with GSK tags placed after residue 40, 29, 157, 178, and 237 were 
phosphorylated by the host cell, indicating that these residues are located on the inside of 
the host cell membrane (Tang 2018). Unfortunately, the GSK tag does not provide any 
information on the segments of the translocators that remain outside the cell.  
In order to further understand the topology of the translocator, PopD, we have 
created three different strains with a ybbR tag inserted after different residues in PopD. 
The ybbR tag, an 11-residue peptide (DSLEFIASKLA), can be labeled by Sfp 
phosphoopantetheinyl transferase (Sfp) with small molecule-CoA conjugates (Yin et al 
2005). Sfp transfers the 4’-phosphopantetheinyl group of CoA onto the serine residue in 
the ybbR peptide and can also transfer small molecules that are attached to CoA, such as 
the fluorophore Alexa488.  
By infecting HeLa cells with these strains and subsequently labeling inserted 
PopD with Alexa488-CoA, it will be possible to determine if the residues are exposed to 
the extracellular media or not. It is also necessary to confirm the functionality of 
modified PopD because without proper secretion and insertion in the membrane, it will 
be impossible to use as a target for Alexa488-CoA labeling. In other words, if the 
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modified PopD cannot form a functional translocon in the host cell membrane, the 
translocon may not be inserted properly and any structural information we obtain would 
be inaccurate.  
We chose to insert the ybbR tag after residue Q40, I83, and S208. While it has 
already been shown that residue V29, Q40, K157, D178, and E237 located in the N 
terminus of PopD, is exposed to the host cell cytosol, the location of the two other 
residues is unknown but predicted to be exposed to the extracellular media (Tang 2018). 
Additionally, it has been shown that a GSK tag insertion after residue S208 does not 
impede translocon formation (Tang 2018). However, the effect of any tag insertion after 
residue I83 has yet to be characterized.  
3.2.1 ybbR-tagged PopD strains secrete PopB and PopD  
           In order to expand upon our knowledge of the topology of PopD inserted in HeLa 
cell membranes, we created three different plasmids with a ybbR tag inserted after 
residue Q40, I83, and S208 in PopD. The Q40 substitution is predicted to be exposed to 
the host cell cytosol, so is therefore the negative control for the labeling assay. The I83 
and S208 residue are both predicted to be exposed to the extracellular media. The 
plasmids were then transformed into P. aeruginosa PAK ∆popD strains. As a negative 
control for PopD secretion, P. aeruginosa PAK ∆popD was transformed with an empty 
plasmid (pUCP18) while our positive control was P. aeruginosa PAK ∆popD 
complemented with a plasmid containing PopD WT.  
In order to test that the ybbR-tag strains can secrete both translocators at levels 
comparable to wild-type, secretion was induced by inducing low calcium conditions. It 
has been shown that low calcium can cause T3S upregulation and secretion (Goure 2004, 
Vallis 1999). Culture media containing the secreted protein was separated from bacteria 
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and precipitated by TCA. Samples were analyzed by western blotting against PopB and 
PopD antibodies (Figure 3.3). Blots were subsequently analyzed by comparing band 
intensity between samples using ImageJ (Figure 3.4). The strains complemented with 
ybbR-tagged PopD secreted levels comparable to the one observed for PopD WT.  
3.2.2 PopD with a ybbR tag after residue 40 and 208 but not 83 can form a 
functional translocon on HeLa cell membranes 
To test if the ybbR tag insertion affects the function of PopD to infect mammalian 
cells, we incubated HeLa cells with the indicated strain at a bacteria:cell ratio of 10:1 
(multiplicity of infection, or MOI, 10) and screened for cell rounding, an indicator of 
HeLa cell distress (Fig. 3.5). After a 2.5 hour-long infection, cell rounding was observed 
in the cells infected with PAK strains containing PopD WT and the strains with the ybbR 
tags inserted after residue 40 and 208 (Figure 3.5). The strain with PopD 40-ybbR caused 
cell rounding at rate comparable to PopD WT, causing HeLa cells to detach from the 
plates after 2.5 hours of infection. While at 2.5 hours the PopD 208-ybbR had only 
caused HeLa cells to round and not detach, extending the infection caused the cells to all 
round and detach (data not shown). In contrast to the other two ybbR-tagged strains, the 
PopD 83-ybbR strain exhibited no cell rounding (Figure 3.5). In fact, there was no 
noticeable difference between HeLa cells infected with PAK ∆popD:pUCP18 or PAK 
∆popD::popD 83-ybbR, even at longer time points. These results demonstrate that the 
addition of the ybbR tag after residue 40 and 208 of PopD does not impede the formation 
of a functional translocon, but the insertion after residue 83 does. 
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Figure 3.3 Secretion of T3S translocators in strains containing modified PopD. P. 
aeruginosa cultures containing the indicated PopD were induced to secrete in low 
calcium conditions. Protein was collected and precipitated by TCA and analyzed using 
SDS-PAGE and western blot. Antibodies used were a mixture of polyclonal anti-PopB 
and anti-PopD antibodies.  
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Figure 3.4 Graphical representation of PopD secretion, normalized to PopB secretion. 
Band intensity was quantified using ImageJ. PopD band intensity was normalized to 
PopB band intensity. Bars represent average of two experiments and error bars show the 
range.  
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Figure 3.5 PAK ∆popD strains complemented with ybbR-tagged PopD cause cell 
rounding in HeLa cells. HeLa cells were infected with P. aeruginosa PAK complemented 
with the indicated plasmid. Representative images at 30 min of infection (top row) and 
2.5 hours of infection (bottom row) are shown. Multiplicity of infection (MOI) 10. 
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3.2.3 PopB and PopD bind to HeLa cell membranes 
In addition to measuring the HeLa cell rounding, we also compared the amount of 
PopB and PopD inserted on HeLa cell membranes after infection. Following the protocol 
published by Tang et al (2018), HeLa cells were infected with an effector-less ∆popD 
PAK strain complemented by the empty pUCP18 plasmid, a plasmid containing PopD 
WT, or the tagged PopD plasmids. Following infection, the bacteria-infected cell 
membrane was isolated and membrane bound translocators were analyzed via western 
blot (Figure 3.6). Both translocators, PopB and PopD, were detected bound to HeLa cell 
membranes in all of the ybbR-tagged strains.  
3.2.4 GST-ybbR can be labeled in the presence of HeLa cells 
In order to confirm that the labeling reaction is able to take place in the presence 
of HeLa cells, ybbR-tagged glutathione-S-transferase (GST-ybbR) was added to a flask 
containing HeLa cells. A total of 2 mL of the labeling reaction containing Sfp and 
Alexa488 conjugated CoA was added to the flask and allowed to incubate for 2 hours at 
room temperature. The media containing labeled GST-ybbR was removed and scanned 
with a GE Typhoon phosphorimager (Figure 3.7). The presence of the band at 
approximately 26 kDa indicates that GST was successfully labeled in the presence of 
HeLa cells. In other words, the labeling reaction takes place under our experimental 
conditions.  
3.2.5 PopD 40-ybbR can be secreted into the media and labeled with Alexa488 
With the necessary characterization in place, we were able to proceed and attempt 
to label ybbR-tagged PopD in vivo by infecting HeLa cells with ybbR-tagged PopD and 
adding the labeling reaction after removing the bacteria. Unfortunately, this yielded no  
 
 
  50 
 
 
 
 
 
Figure 3.6 Binding of translocators to HeLa cell membranes. HeLa cells were infected 
with an effector less P. aeruginosa PAK strain (PAK ∆ESTY ∆D) complemented with 
the indicated plasmid at an MOI of 30. The membrane fractions were isolated and 
chloroform/methanol precipitated before being analyzed via western blot. 20 ng of total 
protein was loaded per lane.  
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Figure 3.7 GST-ybbR is successfully labeled with Alexa488 in the presence of HeLa 
cells. GST-ybbR was added to a flask containing HeLa cells, Sfp, and Alexa488-CoA. 
The solution containing GST-ybbR was removed and chloroform/methanol precipitated 
and 0.2 µg of protein was loaded onto a 12.5% acrylamide SDS-PAGE gel. Gel was 
imaged with a GE Typhoon phosphorimager. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  52 
visible bands when imaging the gel, which led us to see if ybbR-tagged PopD could be 
secreted by P. aeruginosa and labeled without being inserted in the membrane. 
To see if the ybbR-tagged PopD constructs could be secreted by P. aeruginosa 
and subsequently be labeled by Alexa-CoA, we induced secretion by creating low-
calcium conditions (as described above). After pelleting the bacteria, Sfp and Alexa488-
CoA was added to the culture containing secreted proteins to label ybbR tagged PopD. 
Out of all of the ybbR-tagged PopD constructs, PopD 40-ybbR was the only one that was 
successfully labeled with Alexa488 (Fig. 3.8).   
3.3 Discussion 
In order to understand the interaction between PopB and PopD on model 
membranes, glutaraldehyde crosslinking was used to study the complexes assembled on 
liposomes. We found that the addition of PopB to PopD redirects the formation of PopD 
homocomplexes to PopB/PopD heterocomplexes when incubated on liposomes, 
suggesting the early formation of heterodimers. This is supported by the finding that 
PopD oligomers do remain associated in the presence of Triton X-100, while PopD-PopB 
oligomer do not.  
To study the regions of the translocators exposed to the extracellular media, we 
created three different strains with ybbR tags inserted after either residue 40, 83, and 208 
in PopD. We then proceeded to characterize the functionality of the ybbR-tagged PopD 
by assessing translocator secretion, HeLa cell cytotoxicity, and HeLa cell membrane 
binding.  
All of the ybbR-tagged PopD constructs were found to secrete both translocators 
at comparable levels to PopD WT (Figure 3.3 and 3.4). In order to quantify PopD 
secretion and control for sample loading, PopD band intensity was normalized to PopB  
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Figure 3.8 PopD 40-ybbR can be labeled by Alexa488-CoA when secreted to the media. 
P. aeruginosa strains containing the indicated plasmids were induced to secrete under 
low calcium conditions. The secreted proteins were isolated and incubated with Sfp and 
Alexa488-CoA to label the ybbR tag. Samples were TCA precipitated and loaded onto a 
12.5% acrylamide gel before being imaged with a GE Typhoon phosphorimager. 
 
 
 
 
 
 
 
 
 
  54 
 
intensity. Because PopB was not modified in any of the strains used, the secretion of 
PopB should have been the same in every strain tested. 
 
While all of the ybbR-tagged strains were able to secrete both translocators, there 
were differences in HeLa cell cytoxicity. We found that only the strains containing 
PopD40-ybbR and PopD208-ybbR exhibited cell rounding comparable to ∆popD::PopD 
WT (Figure 3.5). These results were expected based on the successful insertion of a GSK 
tag after residues 40 and 208 used by Tang et al (2018). However, PopD83-ybbR 
appeared to cause no cell rounding compared to PopD WT, even when infection times 
were extended. While PopD83-ybbR is secreted, the lack of cell rounding indicates that 
PopD83-ybbR may not adopt the correct orientation or insert into the HeLa cell 
membrane.  
We were able to confirm that all three PopD derivatives were able to associate 
with HeLa cell membranes (Figure 3.6). By infecting HeLa cells with an effector less P. 
aeruginosa PAK ∆ESTY ∆popD strain complemented with a plasmid containing no 
PopD, PopD WT, or ybbR-tagged PopD, and subsequently isolating the membrane-
bound proteins, we were able to confirm the ability of P. aeruginosa to successfully 
inject a translocon containing ybbR-tagged PopD that can bind to the cell membrane.  
Lastly, we were able to show that the labeling reaction was able to take place in 
the presence of HeLa cells (Figure 3.7). Further, by controlling the amount of substrate to 
be labeled we now have a benchmark for the amount of substrate necessary to produce a 
visible band in the gel.  
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While these positive results indicated that we are able to move forward and 
attempt to label the ybbR tag in vivo with Alexa488-CoA using Sfp 
phosphoopantetheinyl transferase, such attempts were not successful. However, we were 
able to confirm that PopD 40-ybbR can be labeled when it is secreted to the media 
(Figure 3.8).  This corroborates previous studies, which have shown that residue Q40 in 
PopD is exposed to the cytosol when inserted in HeLa cell membranes (Tang et al 2018). 
However, when inserted into the membrane, we expect that the ybbR tag inserted after 
residue 40 will not be labeled by Alexa488-CoA, and it will serve as a negative control 
for the labeling reaction. However, it is unclear where the other two locations with a 
ybbR tag (residue 83 and 208) are located when a functional PopB/PopD translocon is 
assembled in HeLa cell membranes. Because the strains containing PopD83-ybbR do not 
form functional translocons, this construct will not be used in the analysis.   
3.4 Materials and methods 
3.4.1 Purification of PopB and PopD 
As described previously in Romano et al 2011. 
3.4.2 Liposome preparation 
As described in 2.4.4. Briefly, all lipids except cholesterol (Steraloids) were 
purchased from Avanti Polar Lipids and are stored as solutions dissolved in chloroform. 
Lipids were mixed in the following ratios: 65 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphocholine (POPC), 15 mol% 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine 
(POPS), and 20 mol% cholesterol (Steraloids, RI) to a final concentration of 30 mM.   
3.4.3 Crosslinking  
Purified PopD alone or a mixture of PopD and PopB in 6 M Urea, and NaCl, 
glycine, and Tris (20mM, pH 8) were diluted and incubated with liposomes in a total of 
200 µl 20 mM sodium acetate, pH 4 for 20 min at room temperature (20-23˚C). Final 
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concentrations were 800 nM total protein and 4.8 mM total lipids. The pH of the reaction 
was raised to neutral (pH 7) titration with buffer containing 1 M Hepes pH 8.0 (~30 µl). 
If detergent was used, prior to crosslinking, Triton X-100 (6.2 µM final concentration) 
was added to reaction for 5 min. A 1% glutaraldehyde solution (Sigma) was freshly 
prepared and added to the reconstitution reaction with a final concentration of 0.01% 
glutaraldehyde. This reaction was incubated for 2 min at room temperature and stopped 
with the addition of 1 M Tris, pH 8.0 to a final concentration of 150 mM and allowed to 
incubate for 20 min at room temperature. The sample was then TCA precipitated and 
resuspended in 20µL loading buffer (4% 2-mercaptoethanol, 50 mM Tris pH 6.8, 10% 
v/v glycerol, 2% w/v SDS, 5 mM EDTA, 0.02% bromophenol blue). This sample was 
run on a 4-12% ExpressPlus PAGE gels (GenScript), and probed for PopD by 
immunoblotting using anti-PopD (diluted 1: 4000) polyclonal antibodies.  
3.4.4 Western blot 
As described previously in Tang et al 2018. In the case of crosslinking, protein 
was separated on a 4-12% ExpressPlus PAGE gels. Others were run on 12.5% 
acrylamide SDS-PAGE gels. 
3.4.5 HeLa cell rounding 
HeLa cells were seeded at confluency on 6-well plates (Falcon) prior to the 
addition of indicated P. aeruginosa strains at an MOI of 10. HeLa cells were monitored 
every half hour and screened for cell rounding.  
3.4.6 Secretion assay 
 Overnight (ON) cultures were set up in autoclaved glass test tubes with a total 
volume of 4 mL with 300 µg/mL carbenicillin and incubated at 37 ˚C at 225 rpm. The 
following morning, they were diluted to obtain 3 mL of OD600 0.1-0.15 with fresh LB 
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(no antibiotics) and grown for an additional 2 hrs shaking at 37˚C. Secretion of T3S 
substrates was induced with EGTA (5 mM final concentration) and MgCl2 (20 mM final 
concentration). Bacteria were allowed to grow for additional 1.5 hrs under the low 
calcium condition. Aliquots of 1 ml of bacterial culture were pelleted at 16,000 x g for 15 
min, and were normalized by measuring OD600 using rest of the culture and were diluted 
further with LB if needed. Quantification of secreted proteins will be normalized to same 
number of bacteria calculated using OD600 of 1 = 2 x 108 cells. The cleared supernatant 
containing secreted proteins was collected and precipitated by TCA. Samples were 
analyzed by immunoblotting using anti-PopB (diluted 1:200,000) and anti-PopD (diluted 
1:4,000) antibodies. The secreted amount of PopB and PopD were quantified using 
ImageJ. In the case of Alexa488-CoA labeling, the labeling reaction was added directly 
to the supernatant to a final concentration of 100 mM MgCl2, 50 mM Hepes pH 7.5, 1 
µM Sfp, and 5 µM Alexa488-CoA and allowed to incubate at 20-23 ˚C for one hour. 
Samples were TCA precipitated and analyzed by running on an SDS-PAGE prior to 
imaging with a GE Typhoon phosphorimager.  
3.4.7 HeLa cell binding 
As described in Tang et al 2018. 
3.4.8 GST-ybbR labeling in presence of HeLa cells 
HeLa cells were cultured in T25 flasks (Corning) and the media (DMEM, Hyclone) 
was removed prior to washing 3x with DPBS (Hyclone). To the flask, 2 mL of a labeling 
reaction was added containing a final concentration of 100 mM MgCl2, 50 mM Hepes pH 
7.5, 1 µM Sfp, 5 µM Alexa488-CoA and 5 µM GST-ybbR. The GST-ybbR, Sfp, and 
Alexa488-CoA were given by Fabian Romano.  
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 CHAPTER 4 
 CONCLUSION 
 
 
 
4.1 Summary of the effect of a fluorophore-modified Cys on PFO binding and pore 
formation 
To modify the Cys459 residue, we used two thiol-reactive fluorescent labels: 
IANBD (NBD) and acrylodan. In addition to the change in binding threshold that a Cys 
modification would produce, the presence of environmentally sensitive fluorophores 
allowed us to directly monitor the interaction of the undecapeptide with the membrane. 
By using a series of assays that measure the cholesterol-dependence of these PFO 
derivatives on model membranes, its ability to form pores, and their hemolytic activity on 
sheep red blood cells, we characterized how these modifications alter the cholesterol 
recognition properties of wild type PFO. 
In comparison to wtPFO, we found that the modification to the Cys residue with 
acrylodan or NBD did not have a significant impact on the cholesterol binding threshold. 
However, the labeled derivatives were not as efficient as wtPFO in forming pores in both 
naturally cholesterol-containing membranes and liposomes. These results tell us that 
while the modification on D4 did not significantly affect cholesterol recognition, there 
was an impact on the ability to insert the β hairpins to form a pore. These results suggest 
that Cys459 may be involved in the allosteric conformational changes that trigger 
oligomerization and insertion of the β-barrel.  
4.1.1 Future directions 
It was previously demonstrated that using a thiol-blocking agent on the conserved 
Cys in wtPFO can block hemolytic activity, suggesting that this Cys residue is important 
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for binding and ultimately pore formation (Iwamoto et al 1987). However, the 
mechanism for this inhibition was unclear. Based on our results, the addition of a 
hydrophobic thiol-reactive probe is not enough to inactivate the toxin. Therefore, it would 
be interesting to observe effect of other Cys modifications on cholesterol binding and 
pore formation. For example, introducing molecules with either a positive or a negative 
charge and measuring cholesterol binding would give insights on the interaction between 
PFO and the membrane.  
4.2 Summary of T3S system translocon analysis 
We have shown that PopB and PopD interact on membranes to form 
heterocomplexes. Additionally, we have begun the characterization of a P. aeruginosa 
PopD knockout strain complemented with ybbR-tagged PopD in the hopes of labeling the 
ybbR tag in vivo. A ybbR tag was inserted after three different residues in PopD, residue 
Q40, I83, and S208, and the plasmids containing these ybbR-tagged PopD constructs 
were transformed into P. aeruginosa PAK PopD-knockout strains. These strains were 
characterized by their HeLa cell cytotoxicity through cell rounding, ability to secrete both 
translocators, and ability to bind to HeLa cell membranes. Additionally, we were able to 
show that the labeling reaction is able to proceed in the presence of HeLa cells by 
labeling GST-ybbR in the presence of HeLa cells. However, we were unable to 
successfully label any of the tags in vivo.  
4.2.1 Future directions 
Based on our positive labeling results, in order to successfully label PopD in vivo 
and analyze the position of the residues, the conditions for labeling will have to be 
optimized. While we have shown that the translocators in PopD40-ybbR and PopD208-
ybbR are functional and able to bind to HeLa cell membranes, in vivo labeling was not 
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successful. This may be because there is not enough substrate present for Sfp to label, in 
which case the experiment would need to be scaled up or a more sensitive method of 
screening for labeling will need to be explored. By using a Typhoon phosphorimager, we 
are able to detect as low as 0.2 µg of labeled protein. If our in vivo labeling is unable to 
produce 0.2 µg of labeled PopD, it will be necessary to explore other more sensitive 
methods of fluorophore detection, such as fluorescent microscopy. Additionally, 
increasing the sample would be costly; therefore, a more sensitive method of fluorophore 
detection would be more practical.  
However, there are other labeling methods that would avoid this issue. Because 
PopD does not have a native cysteine, introducing a Cys substitution would allow us to 
perform PEGylation assays. By using PEG-maleimide, a reagent that reacts with the 
sulfhydryl group of the cysteine, we would be able to observe a shift in the molecular 
weight of PopD if the Cys residue is exposed or not. This assay would also avoid the 
need for increasing sample size because the antibodies we have are already sensitive 
enough to detect the amount of PopD that is bound to HeLa cell membranes. 
Additionally, because our PopD83-ybbR construct was not able to form a functional 
translocon on HeLa cell membranes, in order to understand the position of this residue it 
will be necessary to pursue other types of labeling reactions. It is possible that the ybbR 
tag interferes with proper insertion and therefore a less intrusive modification might be 
more successful. For these reason, a Cys substitution and PEGylation assay would be a 
practical method to explore the topology of PopD. 
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APPENDIX 
SOME CHARACTERIZATION OF THE INACTIVE PFO 
TOXIN, pPFO  
 
 
 
A.1 Labeling of of pPFO with Alexa488 does not affect the cholesterol threshold 
Due to the lytic properties exhibited by full-length PFO, there has been a need for 
non-lytic cholesterol probes. One such probe was generated by Johnson et al that 
contained four amino acid substitutions: C459A, E167C, Y181A, and F318A, generating 
a so-called parental PFO, or pPFO (Johnson et al 2017). The Cys substitutions allow for 
labeling on a residue that does not interact with the membrane and the Y181A and F318A 
substitutions render the toxin inactive (Johnson et al 2017). Here, the effect of labeling 
E167C with Alexa488 on the cholesterol binding threshold was measured.  
In order to see if Alexa labeling interfered with the cholesterol binding threshold 
of pPFO, the cholesterol binding curve of Alexa488-labeled pPFO was compared to the 
curve for unlabeled pPFO. Alexa488-labeled pPFO or pPFO were incubated with 
liposomes containing 30-42 mol% cholesterol and the resultant increase in Trp 
fluorescence was measured. There was no difference in the cholesterol binding threshold 
between Alexa488-labeled pPFO and unlabeled pPFO (A0.1).  
A.2 Cholesterol-dependent binding isotherms for pPFO 
In order to observe the effect of high concentrations of pPFO on the typical 
sigmoidal cholesterol binding curve, different concentrations of pPFO were incubated 
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with liposomes. Following incubation, the resultant increase in Trp fluorescence was 
compared to the initial fluorescence. We found that at high concentrations of protein, the  
 
 
 
Figure A.1 Labeling of pPFO with Alexa488 does not affect the cholesterol threshold. 
pPFO (open circles) and pPFOAlexa488 (filled circles) were added to a final concentration 
of 0.2 µM, and incubated with liposomes of varying cholesterol concentrations and a 
constant 1:1:1 molar ratio of POPC, POPE, and SM (final total lipid concentration of 0.2 
mM). PFO binding was determined using the intrinsic Trp emission before (F0) and after 
addition of liposomes (F) at 20 oC. Values at each cholesterol mol % are the average of 
two measurements and the errors bars indicate the range. Published in Johnson et al 2017. 
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Figure A.2 Cholesterol-dependent binding isotherms for pPFO. pPFO at the indicated 
final concentration was incubated in 50 mM buffer Hepes pH 7.5, 100 mM NaCl, 1mM 
DTT, and 0.5 mM EDTA with liposomes of varying cholesterol concentrations and a 
constant 1:1:1 molar ratio of POPC, POPE, and SM (final total lipid concentration of 50 
µM). Samples were incubated for 20 min at 37 °C in a final volume of 300 µL. PFO 
binding was determined using the intrinsic Trp emission at 20 oC before (F0) and after 
addition of liposomes (F) as described in methods. Values at each cholesterol mol % are 
the average of two measurements and the errors bars indicate the range. Published in 
Johnson et al 2017. 
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typical sigmoidal curve becomes linear (Fig. A0.2). These results corroborated the 
findings in Johnson et al which suggested that high concentrations of pPFO saturate the 
membrane of RAW264.7 cells (Johnson et al 2017). 
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